Skip to content

Usability study of a new walking aid prototype, the ROLL-WALKERS®

Usability study of a new walking aid prototype, the ROLL-WALKERS®

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00011074
Enrollment
12
Registered
2016-11-17
Start date
2016-12-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

safety and usability while walking with a new walking device for the elderly

Interventions

Group 1: Walking with the Roll walker device and performing some typical daily activity tasks

Sponsors

Zürcher Hochschule für angewandte Wissenschaften (ZHAW)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult inhabitants of a retirement home with impaired mobility. Walk for at least 3 months with a wheeled walker. Between 150 and 185 cm tall, less or equal than 120 kg heavy. Cognitive able to decide for themselves whether to participate or not and to rate the Roll Walker device

Exclusion criteria

Exclusion criteria: Falls within the last 2 weeks, Surgery affecting the musculoskeletal system within the last 3 months. Catheter and/or infusion. Acute diseases. Cognitive impairments as to not been able to decide on their own to participate or not and/or rate the device under study.

Design outcomes

Primary

MeasureTime frame
frequencies and severity of use errors occuring during the use of the new walking device will be assessed by an observational physiotherapist

Secondary

MeasureTime frame
help needed from an assisting person and assessed by an observational physiotherapist. Comfort, design will be evaluated by questionnaire.

Countries

Switzerland

Contacts

Public ContactKarin Niedermann

Zürcher Hochschule für angewandte Wissenschaften (ZHAW)

nika@zhaw.ch+41 58 934 6346

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026